Cepheid's Next-Generation MRSA Screening Test Gets CE Mark | GenomeWeb

NEW YORK (GenomeWeb) – Cepheid today announced it has received CE marking for a next-generation version of its molecular test for methicillin-resistant Staphylococcus aureus.

The Xpert MRSA NxG identifies mecA- and mecC-containing strains of MRSA as well emerging SCCmec subtypes. It has enhanced features, including room-temperature storage, validation on multiple swab types, and the ability to rule out empty cassette strains, the firm noted in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.